Business NewsMarketWire • Plandai Has Huge Opportunity With Its Malaria Treatment

Plandai Has Huge Opportunity With Its Malaria Treatment

Plandai Has Huge Opportunity With Its Malaria Treatment

BALTIMORE, MD--(Marketwired - May 31, 2013) - Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, posits that given its high degree of bioavailability Plandai Biotechnology, Inc. (OTCQB: PLPL) could change the way the market and consumer utilize green tea extracts. Plandai Biotechnology, Inc. (OTCQB: PLPL) is a developer of highly bioavailable, phytonutrient rich extracts, which are being utilized to deliver a new family of drugs to safely and affordably treat a multitude of diseases and conditions.  

View More : http://www.marketwire.com/mw/release.do?id=1796819&sourceType=3
Releted News by marketwire
INSCOR's Offerings Aid Wealthy Individuals
Plandai Has Huge Opportunity With Its Malaria Treatment
Sama Resources Closes Private Placement of CAN$2,565,000